Shyam Srinivasan
Stock Analyst at Goldman Sachs
(0.27)
# 4,296
Out of 4,520 analysts
83
Total ratings
48.1%
Success rate
-11.7%
Average return
Main Sectors:
Stocks Rated by Shyam Srinivasan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: DIVISLAB Divi's Laboratories Limited | Upgraded: Buy | ₹6,375 → ₹8,035 | ₹7,248 | +10.87% | 6 | May 29, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Downgraded: Sell | ₹1,200 → ₹1,075 | ₹1,211 | -11.25% | 6 | Apr 23, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹7,850 → ₹8,550 | ₹8,826 | -3.13% | 2 | Dec 7, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Downgraded: Hold | ₹700.00 → ₹965.00 | ₹952.45 | +1.32% | 2 | Dec 7, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Initiated Coverage: Buy | ₹900.00 | ₹802.95 | +12.09% | 1 | Dec 7, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Initiated Coverage: Buy | ₹1,325 | ₹1,090 | +21.57% | 1 | Dec 7, 2025 | |
| NSE: ICICIPRULI ICICI Prudential Life Insurance Company Limited | Maintained: Hold | ₹625.00 → ₹650.00 | ₹497.15 | +30.75% | 3 | Oct 15, 2025 | |
| NSE: LAURUSLABS Laurus Labs Limited | Maintained: Sell | ₹675.00 → ₹750.00 | ₹1,530 | -50.97% | 8 | Oct 14, 2025 | |
| NSE: NEULANDLAB Neuland Laboratories Limited | Maintained: Buy | ₹15,750 → ₹17,225 | ₹18,434 | -6.56% | 5 | Oct 14, 2025 | |
| NSE: BIOCON Biocon Limited | Maintained: Hold | ₹345.00 → ₹335.00 | ₹437.20 | -23.38% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹800.00 → ₹775.00 | ₹417.45 | +85.65% | 5 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,300 → ₹1,250 | ₹1,533 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,375 → ₹1,350 | ₹1,419 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,435 → ₹1,525 | ₹2,449 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,975 | ₹2,443 | n/a | 4 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹265.00 → ₹250.00 | ₹179.42 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹830.00 → ₹890.00 | ₹563.65 | n/a | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹465.00 | ₹433.10 | n/a | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,860 → ₹2,015 | ₹1,829 | n/a | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,650 → ₹1,680 | ₹1,854 | n/a | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,325 | ₹1,687 | n/a | 1 | Apr 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,475 → ₹1,500 | ₹1,933 | n/a | 4 | Apr 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,350 | ₹441.90 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,675 | ₹545.30 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,975 | ₹1,612 | n/a | 1 | Jan 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.94 | n/a | 1 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $12.60 | n/a | 1 | May 2, 2016 |
Divi's Laboratories Limited
May 29, 2026
Upgraded: Buy
Price Target: ₹6,375 → ₹8,035
Current: ₹7,248
Upside: +10.87%
Dr. Reddy's Laboratories Limited
Apr 23, 2026
Downgraded: Sell
Price Target: ₹1,200 → ₹1,075
Current: ₹1,211
Upside: -11.25%
Apollo Hospitals Enterprise Limited
Dec 7, 2025
Maintained: Buy
Price Target: ₹7,850 → ₹8,550
Current: ₹8,826
Upside: -3.13%
Fortis Healthcare Limited
Dec 7, 2025
Downgraded: Hold
Price Target: ₹700.00 → ₹965.00
Current: ₹952.45
Upside: +1.32%
Krishna Institute of Medical Sciences Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹900.00
Current: ₹802.95
Upside: +12.09%
Max Healthcare Institute Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹1,325
Current: ₹1,090
Upside: +21.57%
ICICI Prudential Life Insurance Company Limited
Oct 15, 2025
Maintained: Hold
Price Target: ₹625.00 → ₹650.00
Current: ₹497.15
Upside: +30.75%
Laurus Labs Limited
Oct 14, 2025
Maintained: Sell
Price Target: ₹675.00 → ₹750.00
Current: ₹1,530
Upside: -50.97%
Neuland Laboratories Limited
Oct 14, 2025
Maintained: Buy
Price Target: ₹15,750 → ₹17,225
Current: ₹18,434
Upside: -6.56%
Biocon Limited
Aug 8, 2025
Maintained: Hold
Price Target: ₹345.00 → ₹335.00
Current: ₹437.20
Upside: -23.38%
Jul 24, 2025
Maintained: Buy
Price Target: ₹800.00 → ₹775.00
Current: ₹417.45
Upside: +85.65%
Jul 15, 2025
Maintained: Buy
Price Target: ₹1,300 → ₹1,250
Current: ₹1,533
Upside: n/a
Jul 15, 2025
Maintained: Sell
Price Target: ₹1,375 → ₹1,350
Current: ₹1,419
Upside: n/a
Jul 15, 2025
Maintained: Sell
Price Target: ₹1,435 → ₹1,525
Current: ₹2,449
Upside: n/a
Jul 15, 2025
Maintained: Hold
Price Target: ₹1,975
Current: ₹2,443
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: ₹265.00 → ₹250.00
Current: ₹179.42
Upside: n/a
Jul 8, 2025
Maintained: Buy
Price Target: ₹830.00 → ₹890.00
Current: ₹563.65
Upside: n/a
Jul 8, 2025
Maintained: Hold
Price Target: ₹465.00
Current: ₹433.10
Upside: n/a
Jul 8, 2025
Maintained: Buy
Price Target: ₹1,860 → ₹2,015
Current: ₹1,829
Upside: n/a
May 2, 2025
Maintained: Sell
Price Target: ₹1,650 → ₹1,680
Current: ₹1,854
Upside: n/a
Apr 26, 2025
Maintained: Sell
Price Target: ₹1,325
Current: ₹1,687
Upside: n/a
Apr 18, 2025
Maintained: Sell
Price Target: ₹1,475 → ₹1,500
Current: ₹1,933
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: ₹1,350
Current: ₹441.90
Upside: n/a
Feb 6, 2025
Maintained: Sell
Price Target: ₹1,675
Current: ₹545.30
Upside: n/a
Jan 19, 2025
Maintained: Hold
Price Target: ₹1,975
Current: ₹1,612
Upside: n/a
Jul 26, 2021
Maintained: Hold
Price Target: n/a
Current: $0.94
Upside: n/a
May 2, 2016
Initiated Coverage: Hold
Price Target: n/a
Current: $12.60
Upside: n/a